Crohn’s Disease The Complete Guide to Medical Management May 1st Edition by Gary R Lichtenstein – Ebook PDF Instant Download/Delivery:1556429444 978-1556429446
Full download Crohn’s Disease The Complete Guide to Medical Management May 1st Edition after payment

Product details:
ISBN 10:1556429444
ISBN 13:978-1556429446
Author:Gary R Lichtenstein
Crohn’s Disease: The Complete Guide to Medical Management serves as the definitive source for medical management of Crohn’s Disease (CD).
Dr. Gary R. Lichtenstein, along with Dr. Ellen J. Scherl, have collaborated with over 60 experts from around the world to provide gastroenterologists and those in training with the necessary information to successfully manage the patient with Crohn’s disease.
Sections Include:
- General
-
- The role of the FDA in drug development; pediatric considerations; disease modifiers; and more
- Medications
-
- Antibiotic use in treatment of CD; oral budesonide; infliximab; novel biological and non biologic therapies for CD; and more
- Specific Clinical Scenarios
-
- Management of steroid unresponsive CD; management of enteric fistulae; use of pre- and probiotics; medical management of short bowel syndrome; maintenance therapy of CD; and more
Features:
- Color images, graphs, and tables
- Extensive index that includes cross-referencing to Ulcerative Colitis: The Complete Guide to Medical Management
- An appendix on Infliximab treatment
- Comprehensive references at the end of each chapter
Organized into an easy-to-reference format, Crohn’s Disease: The Complete Guide to Medical Management threads theory into practice and provides Gastroenterology professionals with the most comprehensive information available on this disease state.
The other side of inflammatory bowel disease is covered in Drs. Gary R. Lichtenstein and Ellen J. Scherl’s Ulcerative Colitis: The Complete Guide to Medical Management. All gastroenterologists will find both books to be essential for future practice in the treatment and care of their patients with either Crohn’s disease or ulcerative colitis, as well as in the overall management of those with inflammatory bowel disease.
Table of contents:
Chapter 1 The Natural History of Inflammatory Bowel Disease
Pietro G. Andres, MD and Lawrence S. Friedman, MD
Chapter 2 Clinical Research in Inflammatory Bowel Disease: Placebo Response in Clinical Trials
Chinyu Su, MD and James D. Lewis, MD, MSCE
Chapter 3 The Role of the FDA in Drug Development in Inflammatory Bowel Disease
Alan C. Moss, MD and Adam Cheifetz, MD
Chapter 4 Utility of Animal Models for the Study and Treatment of Inflammatory Bowel Disease
Ashish Chawla, MD and Kenneth Simpson, BVM&S, PhD
Chapter 5 Pediatric Considerations in Medical Therapy in Patients With Inflammatory Bowel Disease
Louis R. Ghanem, MD, PhD and Robert N. Baldassano, MD
Chapter 6 The Limitations of Applying Evidence-Based Medicine to Inflammatory Bowel Disease:
What We Do Not Learn From Clinical Trials
Joshua R. Korzenik, MD and Corey A. Siegel, MD
Chapter 7 Disease Modifiers in Inflammatory Bowel Disease
Jaime A. Oviedo, MD and Francis A. Farraye, MD, MSc, FACP, FACG
Chapter 8 Fertility and Pregnancy in Inflammatory Bowel Disease
Jeffry A. Katz, MD and Vinita Elizabeth Jacob, MD
Chapter 9 Medication Adherence in Inflammatory Bowel Disease
Sunanda Kane, MD, MSPH, FACG, FACP, AGAF
Section II Medications
Chapter 10 Mesalamine for Maintenance Therapy in Ulcerative Colitis: How Much, How Long?
Miles P. Sparrow, MD, MBBS, FRACP; Wee-Chian Lim, MD, MBBS, MMed, MRCP;
and Stephen B. Hanauer, MD
Chapter 11 Antibiotic Use in the Treatment of CrohnÆs Disease
Manuel Mendizabal, MD; Wojciech Blonski, MD, PhD; David Kotlyar, MD; and Gary R. Lichtenstein, MD, FACP, FACG, AGAF
Chapter 12 Corticosteroids in CrohnÆs Disease
Lene Riis, MD and Pia Munkholm, MD, DMSCi
Chapter 13 Oral Budesonide for Inflammatory Bowel Disease
Gordon R. Greenberg, MD, FRCP(C)
Chapter 14 6-Mercaptopurine and Azathioprine in CrohnÆs Disease
Mark T. Osterman, MD and Gary R. Lichtenstein, MD, FACP, FACG, AGAF
Chapter 15 Methotrexate in the Treatment of CrohnÆs Disease
Ellen J. Scherl, MD, FACP, AGAF; Arun Swaminath, MD; Ryan Urquhart Warren, MD;
and Harrison Lakehomer, BA
Chapter 16 Calcineurin Inhibitors (Cyclosporine A, Tacrolimus, and Sirolimus) and Mycophenolate
Mofetil in CrohnÆs Disease
Gerassimos J. Mantzaris, MD, PhD, AGAF
Chapter 17 Infliximab in CrohnÆs Disease
Lawrence W. Comerford, MD and Stephen J. Bickston, MD, AGAF
Chapter 18 Anti-TNFa Therapy From Symptoms to Molecules:
Impact of Individual Variability on Anti-TNFa Optimization Strategies
Ellen J. Scherl, MD, FACP, AGAF
Chapter 19 Novel Biological Therapies for CrohnÆs Disease
People also search for:
crohn’s disease management guidelines
crohn’s disease management
crohn’s disease medical treatment
crohn’s disease the complete guide to medical management may
crohn’s management guidelines
Tags:
Gary R Lichtenstein,Crohn’s,Disease


